相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Therapy of highly active pediatric multiple sclerosis
Peter Huppke et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Therapy of highly active pediatric multiple sclerosis
Peter Huppke et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study
Damiano Baroncini et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Long-term follow-up of pediatric MS patients starting treatment with injectable first-line agents: A multicentre, Italian, retrospective, observational study
Damiano Baroncini et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Clinical trials of disease-modifying agents in pediatric MS Opportunities, challenges, and recommendations from the IPMSSG
Emmanuelle Waubant et al.
NEUROLOGY (2019)
Long-term Cognitive Outcomes in Patients With Pediatric-Onset vs Adult-Onset Multiple Sclerosis
Kyla A. McKay et al.
JAMA NEUROLOGY (2019)
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis
J. William L. Brown et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)
Raed Alroughani et al.
PEDIATRIC NEUROLOGY (2018)
Trial of Fingolimod versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Tanuja Chitnis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US
Kristen M. Krysko et al.
NEUROLOGY (2018)
Bringing the HEET: The Argument for High-Efficacy Early Treatment for Pediatric-Onset Multiple Sclerosis
Marisa McGinley et al.
NEUROTHERAPEUTICS (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Use of Natalizumab in Pediatric Patients With Active Relapsing Multiple Sclerosis: A Prospective Study
Raed Alroughani et al.
PEDIATRIC NEUROLOGY (2017)
Rituximab in paediatric onset multiple sclerosis: a case series
Jonatan Salzer et al.
JOURNAL OF NEUROLOGY (2016)
Specifying a target trial prevents immortal time bias and other self-inflicted injuries in observational analyses
Miguel A. Hernan et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study
Naila Makhani et al.
PEDIATRIC NEUROLOGY (2016)
Natalizumab in the pediatric MS population: results of the Italian registry
Angelo Ghezzi et al.
BMC NEUROLOGY (2015)
Fingolimod Prescribed for the Treatment of Multiple Sclerosis in Patients Younger Than Age 18 Years
Yara Dadalti Fragoso et al.
PEDIATRIC NEUROLOGY (2015)
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps
T. Charles Casper et al.
JOURNAL OF CHILD NEUROLOGY (2015)
Rituximab Use in Pediatric Central Demyelinating Disease
Shannon J. Beres et al.
PEDIATRIC NEUROLOGY (2014)
Confidence interval estimation for number of patient-years needed to treat
Haiyuan Zhu et al.
PHARMACEUTICAL STATISTICS (2014)
Elevated relapse rates in pediatric compared to adult MS persist for at least 6 years
L. A. Benson et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2014)
Natalizumab use in pediatric patients with relapsing-remitting multiple sclerosis
Carmen Arnal-Garcia et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2013)
Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
Silvia N. Tenembaum et al.
JOURNAL OF CHILD NEUROLOGY (2013)
International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions
Lauren B. Krupp et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Natalizumab Therapy for Highly Active Pediatric Multiple Sclerosis
Barbara Kornek et al.
JAMA NEUROLOGY (2013)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Multiple Sclerosis Therapies in Pediatric Patients With Refractory Multiple Sclerosis
E. Ann Yeh et al.
ARCHIVES OF NEUROLOGY (2011)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Interval censoring
Zhigang Zhang et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2010)
Increased Relapse Rate in Pediatric-Onset Compared With Adult-Onset Multiple Sclerosis
Mark P. Gorman et al.
ARCHIVES OF NEUROLOGY (2009)
Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis
E. A. Yeh et al.
BRAIN (2009)
Effectiveness of early beta interferon on the first attack after confirmed multiple sclerosis: A comparative cohort study
Yann Mikaeloff et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2008)
Natural history of multiple sclerosis with childhood onset
Christel Renoux et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta-1a
H. Pakdaman et al.
NEUROPEDIATRICS (2006)
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
RA Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study
A Ghezzi et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a
D Pohl et al.
NEUROLOGY (2005)
Interferon-β treatment in patients with childhood onset multiple sclerosis
Y Mikaelloff et al.
JOURNAL OF PEDIATRICS (2001)
Interferon beta-1a in children with multiple sclerosis is well tolerated
E Waubant et al.
NEUROPEDIATRICS (2001)
分享论文
